ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 105014 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 105014; 2) Community: the network communities that were significantly associated with the response to NSC 105014; 3) Molecule: the relationships between components within communities and NSC 105014; 4) MDR: the compounds that were significantly associated with the NSC 105014.

NSC Compound Enrichment Correlation
NSC 606497 Camptothecin Derivative 0.000644707050513007 0.58108789
NSC 643836 Null 0.000644707050513007 -0.0073994285
NSC 683556 Camptothecin Derivative 0.000644707050513007 0.56750903
NSC 694620 Null 0.000644707050513007 -0.20243193
NSC 700363 Liposomal Annamycin 0.000644707050513007 0.27641105
NSC 704640 Null 0.000644707050513007 0.23219106
NSC 751620 Null 0.00078227743523216 0.23806905
NSC 631522 Null 0.000837923650101952 0.40333374
NSC 208652 2,4-Quinazolinediamine, 5-chloro-6-[[(3,4-dichlorophenyl)amino]methyl]- 0.000931492155975116 0.37281054
NSC 670656 4a,14a-Epoxy-4,14-[3]hexene[1,5]diynonaphtho[2,3-c] phenanthridine-3,7,12(4H)-trione, 1,2,13,14-tetrahydro-4,6-dihydroxy-1-methyl-, stereoisomer 0.000931492155975116 0.57202919
Total:75  Current:3    [First] [Prev] [Next] [Last]